Indigo is set to disrupt the growing Continuous Glucose Monitor (CGM) market with a long-term insertable optical microchip. 
Indigo’s solution will answer the patient’s need for a hassle-free, invisible CGM without a body-worn device and will address the physician’s quest for a multi-biomarker sensor that also measures lactate and ketones besides just glucose. Personalised diabetes management will be brought to the next level with Indigo’s groundbreaking technology.


Tom Segers

Director of Product Management @ Indigo Diabetes